Summary: H.R.2438 — 114th Congress (2015-2016)All Information (Except Text)

There is one summary for H.R.2438. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (05/19/2015)

This bill requires the Food and Drug Administration to issue guidance that addresses using alternative statistical methods, including adaptive trial design and Bayesian methods, in clinical trials and in the development and review of drugs and biological products.